{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:43:22Z","timestamp":1790711002779,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006181","name":"FAPESB","doi-asserted-by":"crossref","award":["BOL0656\/2014"],"award-info":[{"award-number":["BOL0656\/2014"]}],"id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006181","name":"FAPESB","doi-asserted-by":"crossref","award":["PPP0065\/2010"],"award-info":[{"award-number":["PPP0065\/2010"]}],"id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.etap.2016.01.015","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T15:48:32Z","timestamp":1453477712000},"page":"212-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development"],"prefix":"10.1016","volume":"42","author":[{"given":"Ana Prates","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan Fernandes","family":"do Esp\u00edrito Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Roberto Peres","family":"Line","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria das Gra\u00e7as Farias","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo de Moura","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Bet\u00e2nia Pereira","family":"Toralles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Ribeiro","family":"do Esp\u00edrito Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2016.01.015_bib0005","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/pbc.22681","article-title":"The use of zoledronic acid in pediatric cancer patients","volume":"56","author":"August","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.etap.2016.01.015_bib0010","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review 1: bisphosphonate use in childhood osteoporosis","volume":"94","author":"Bachrach","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.etap.2016.01.015_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/bpo.0b013e3180316d06","article-title":"Intravenous pamidronate therapy in osteogenesis imperfecta: response to treatment and factors influencing outcome","volume":"27","author":"Bajpai","year":"2007","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.etap.2016.01.015_bib0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000365889","article-title":"The use of bisphosphonates in pediatrics","volume":"82","author":"Baroncelli","year":"2014","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.etap.2016.01.015_bib0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/jpem-2012-0016","article-title":"Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta","volume":"25","author":"Barros","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.etap.2016.01.015_bib0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.archoralbio.2012.09.016","article-title":"Effects of zoledronic acid on odontoblast-like cells","volume":"58","author":"Basso","year":"2013","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.etap.2016.01.015_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/aja.1001740107","article-title":"Effects of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on the formation of dentin and the periodontal attachment apparatus in the mouse","volume":"174","author":"Beertsen","year":"1985","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.etap.2016.01.015_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","article-title":"Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability","volume":"49","author":"Bellido","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.etap.2016.01.015_bib0045","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.earlhumdev.2010.08.002","article-title":"Characterising and treating osteogenesis imperfecta","volume":"86","author":"Bishop","year":"2010","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.etap.2016.01.015_bib0050","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Bishop","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.etap.2016.01.015_bib0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00441-007-0499-y","article-title":"Effects of alendronate on tooth eruption and molar root formation in young growing rats","volume":"330","author":"Bradaschia-Correa","year":"2007","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00441-013-1623-9","article-title":"Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats","volume":"353","author":"Bradaschia-Correa","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-8749.2008.03222.x","article-title":"American Academy for Cerebral Palsy and Developmental Medicine Treatment Outcomes Committee Review Panel. Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review","volume":"51","author":"Castillo","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.etap.2016.01.015_bib0070","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1177\/009127002762491316","article-title":"Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases","volume":"42","author":"Chen","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2016.01.015_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11832-012-0383-5","article-title":"Complications of pamidronate therapy in paediatric osteoporosis","volume":"6","author":"Chilbule","year":"2012","journal-title":"J. Child Orthop."},{"key":"10.1016\/j.etap.2016.01.015_bib0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/ipd.12047","article-title":"Bisphosphonate-related osteonecrosis of the jaws and its relevance to children \u2013 a review","volume":"23","author":"Christou","year":"2013","journal-title":"Int. J. Paediatr. Dent."},{"key":"10.1016\/j.etap.2016.01.015_bib0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00223-002-2017-2","article-title":"The role of prenylated small GTP-binding proteins in the regulation of osteoclast function","volume":"72","author":"Coxon","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.etap.2016.01.015_bib0090","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bone.2007.12.225","article-title":"Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells","volume":"42","author":"Coxon","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.etap.2016.01.015_bib0095","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00228-001-0411-8","article-title":"A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis","volume":"57","author":"Cremers","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2016.01.015_bib0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2011.01.014","article-title":"Pharmacology of bisphosphonates","volume":"49","author":"Cremers","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.etap.2016.01.015_bib0105","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1359\/JBMR.050522","article-title":"Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases","volume":"20","author":"Cremers","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/03008200903280115","article-title":"Birefringence of the secretory-stage enamel organic extracellular matrix from rats submitted to successive injections of bisphosphonates","volume":"51","author":"do Esp\u00edrito Santo","year":"2010","journal-title":"Connect. Tissue Res."},{"issue":"7","key":"10.1016\/j.etap.2016.01.015_bib0115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005088.pub3","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","author":"Dwan","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.etap.2016.01.015_bib0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bone.2011.03.774","article-title":"The relationship between the chemistry and biological activity of the bisphosphonates","volume":"49","author":"Ebetino","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.etap.2016.01.015_bib0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40200-014-0109-y","article-title":"Bisphosphonate therapy in pediatric patients","volume":"13","author":"Eghbali-Fatourechi","year":"2014","journal-title":"J. Diab. Metab. Disord."},{"key":"10.1016\/j.etap.2016.01.015_bib0130","series-title":"Oral Development and Histology","first-page":"123","article-title":"Tooth eruption and shedding","author":"ElNesr","year":"2002"},{"key":"10.1016\/j.etap.2016.01.015_bib0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.20344\/amp.4005","article-title":"Osteogenesis imperfecta \u2013 experience of Dona Estef\u00e2nia's Hospital orthopedics\u2019 department","volume":"26","author":"Escobar","year":"2013","journal-title":"Acta Med. Port."},{"key":"10.1016\/j.etap.2016.01.015_bib0140","first-page":"339","article-title":"The effect of a single dose of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on secretory ameloblasts and enamel formation in rat incisors","volume":"18","author":"Fejerskov","year":"1990","journal-title":"J. Biol. Buccale"},{"key":"10.1016\/j.etap.2016.01.015_bib0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","article-title":"Bisphosphonates: mechanisms of action","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocr. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.etap.2016.01.015_bib0150","first-page":"S23","article-title":"Bisphosphonates \u2013 history and experimental basis","volume":"8","author":"Fleisch","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.etap.2016.01.015_bib0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/08959374890030022401","article-title":"Developmental disturbances of the rat molar induced by two diphosphonates","volume":"3","author":"Fouda","year":"1989","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0160","first-page":"106","article-title":"Mineralization disturbances of the developing rat molar induced by mono- and bisphosphonates","volume":"19","author":"Fouda","year":"1991","journal-title":"J. Biol. Buccale"},{"key":"10.1016\/j.etap.2016.01.015_bib0165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0003-9969(00)00009-1","article-title":"Autoradiographic investigation of the effect of 1-hydroxyethylidene, 1-bisphosphonate on matrix protein synthesis and secretion by secretory ameloblasts in rat incisors","volume":"45","author":"Fuangtharnthip","year":"2000","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.etap.2016.01.015_bib0170","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.etap.2016.01.015_bib0175","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2146\/ajhp140041","article-title":"Effects of maternal bisphosphonate use on fetal and neonatal outcomes","volume":"71","author":"Green","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.etap.2016.01.015_bib0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/00220345980770011201","article-title":"Inhibition of tooth eruption in the rat by a bisphosphonate","volume":"77","author":"Grier","year":"1998","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0185","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00223-010-9366-z","article-title":"Administration of the bisphosphonate zoledronic acid during tooth development inhibits tooth eruption and formation and induces dental abnormalities in rats","volume":"86","author":"Hiraga","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.etap.2016.01.015_bib0190","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1016\/j.bjoms.2012.05.008","article-title":"Bisphosphonate-related enamel hypoplasia in a child with idiopathic arterial calcification of infancy","volume":"51","author":"Iwai","year":"2013","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.etap.2016.01.015_bib0195","first-page":"321","article-title":"The effect of a single dose of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on presecretory ameloblast differentiation in rat incisors","volume":"18","author":"Josephsen","year":"1990","journal-title":"J. Biol. Buccale"},{"key":"10.1016\/j.etap.2016.01.015_bib0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-0722.2008.00529.x","article-title":"Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta","volume":"116","author":"Kamoun-Goldrat","year":"2008","journal-title":"Eur. J. Oral Sci."},{"key":"10.1016\/j.etap.2016.01.015_bib0205","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00774-011-0262-z","article-title":"Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta","volume":"29","author":"Kitaoka","year":"2011","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.etap.2016.01.015_bib0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02008217","article-title":"The short-term effects of high doses of ethylene-1-hydroxy-1,1-diphosphonates upon early dentin formation","volume":"16","author":"Larsson","year":"1974","journal-title":"Calcif. Tissue Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0215","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1124\/mol.61.5.1255","article-title":"Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite","volume":"61","author":"Lehenkari","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.etap.2016.01.015_bib0220","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0225","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1651-2227.2003.tb00577.x","article-title":"Treatment of children with osteogenesis imperfecta in Estonia","volume":"92","author":"Maasalu","year":"2003","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.etap.2016.01.015_bib0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","article-title":"Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones","volume":"19","author":"Masarachia","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.etap.2016.01.015_bib0235","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1369\/jhc.5A6853.2006","article-title":"Immunocytochemical study of amelogenin deposition during the early odontogenesis of molars in alendronate-treated newborn rats","volume":"54","author":"Massa","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.etap.2016.01.015_bib0240","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1203\/00006450-200211000-00010","article-title":"Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model","volume":"52","author":"McCarthy","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bjp.0706628","article-title":"A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates","volume":"147","author":"M\u00f6nkk\u00f6nen","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.etap.2016.01.015_bib0250","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/jemt.22059","article-title":"Systemically alendronate was incorporated into dental tissues but did not cause morphological or mechanical changes in rats teeth","volume":"75","author":"Nelson-Filho","year":"2012","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.etap.2016.01.015_bib0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02556239","article-title":"1-Hydroxyethylidene-1,1-bisphosphonate (HEBP) simultaneously induces two distinct types of hypomineralization in the rat incisor dentine","volume":"44","author":"Ogawa","year":"1989","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.etap.2016.01.015_bib0260","first-page":"CD005088","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","author":"Phillipi","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.etap.2016.01.015_bib0265","first-page":"1846","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age","volume":"85","author":"Plotkin","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.etap.2016.01.015_bib0270","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","article-title":"Bisphosphonates: mechanisms of action","volume":"97","author":"Rodan","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.etap.2016.01.015_bib0275","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1359\/jbmr.091009","article-title":"Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo","volume":"25","author":"Roelofs","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","article-title":"Biochemical and molecular mechanisms of action of bisphosphonates","volume":"49","author":"Rogers","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.etap.2016.01.015_bib0285","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.etap.2016.01.015_bib0290","first-page":"2713","article-title":"Combined effects of bisphosphonate and radiation on osteosarcoma cells","volume":"30","author":"Ryu","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1679\/aohc.62.171","article-title":"Intermittent inhibition of dentin mineralization of rat incisors under continual infusion of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) using subcutaneous mini osmotic pump","volume":"62","author":"Sakai","year":"1999","journal-title":"Arch. Histol. Cytol."},{"key":"10.1016\/j.etap.2016.01.015_bib0300","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/08959374870010022701","article-title":"Ultrastructural effects of diphosphonates on dental enamel","volume":"1","author":"Simmelink","year":"1987","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0305","doi-asserted-by":"crossref","first-page":"280","DOI":"10.14310\/horm.2002.1319","article-title":"The use of bisphosphonates in women prior to or during pregnancy and lactation","volume":"10","author":"Stathopoulos","year":"2011","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.etap.2016.01.015_bib0310","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008536","article-title":"Zebra lines in osteogenesis imperfecta on bisphosphonate therapy","author":"Sukumar","year":"2013","journal-title":"BMJ Case Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.etap.2016.01.015_bib0315","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0722.1998.tb02187.x","article-title":"Demonstration of putative Ca-binding domains in dentin matrix of rat incisors after daily injections of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP)","volume":"106","author":"Takano","year":"1998","journal-title":"Eur. J. Oral Sci."},{"key":"10.1016\/j.etap.2016.01.015_bib0320","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/03008209509013700","article-title":"Epithelial\u2013mesenchymal signaling during tooth development","volume":"32","author":"Thesleff","year":"1995","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0325","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S8756-3282(01)00655-X","volume":"30","author":"van Beek","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.etap.2016.01.015_bib0330","first-page":"754","article-title":"Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase\/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo","volume":"263","author":"van Beek","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.etap.2016.01.015_bib0335","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","volume":"164A","author":"Van Dijk","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.etap.2016.01.015_bib0340","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2330\/joralbiosci1965.33.82","article-title":"A study of the effects of successive injections of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on the enamel formation of rat incisor","volume":"33","author":"Wakamatsu","year":"1991","journal-title":"Jpn. J. Oral Biol."},{"key":"10.1016\/j.etap.2016.01.015_bib0345","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.2010-0636","article-title":"Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"96","author":"Ward","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.etap.2016.01.015_bib0350","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0003-9969(90)90064-H","article-title":"Effects of single doses of 1-hydroxyethylidene-1,1-bisphosphonate on the mineralizing front of rat incisor enamel: a microradiographic and scanning electron microscopic study","volume":"35","author":"Weile","year":"1990","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.etap.2016.01.015_bib0355","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF00296658","article-title":"Scanning electron microscopy of final enamel formation in rat mandibular incisors following single injections of 1-hydroxyethylidene-1,1-bisphosphonate","volume":"52","author":"Weile","year":"1993","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.etap.2016.01.015_bib0360","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/154405910808700509","article-title":"Mechanisms of tooth eruption and orthodontic tooth movement","volume":"87","author":"Wise","year":"2008","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.etap.2016.01.015_bib0365","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0003-9969(99)00134-X","article-title":"Gene expression and immunolocalization of amelogenin in enamel hypoplasia induced by successive injections of bisphosphonate in rat incisors","volume":"45","author":"Yamada","year":"2000","journal-title":"Arch. Oral Biol."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668916300151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668916300151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T11:53:42Z","timestamp":1692186822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668916300151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":73,"alternative-id":["S1382668916300151"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2016.01.015","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2016.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}